Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 659
Selected: 0
NCT IDTitle
NCT02223715Prospective Observational Study of Clostridium Difficile Infection in Asian Pacific Countries
NCT03892889A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
NCT00041678Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
NCT02009878A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
NCT00876343Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder
NCT01727726A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
NCT02758067Comparison of the Effectiveness of Brexpiprazole With That of Risperidone
NCT03292848Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
NCT02914548Study of OPA-15406 Ointment in Patients With Atopic Dermatitis
NCT01413178A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
NCT02442674A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia
NCT00392197Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-
NCT00576706PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity
NCT00401271Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis
NCT01567527Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
NCT01876381A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
NCT06114628Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
NCT05650320To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients with AD
NCT01022424A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002]
NCT00130039Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II
NCT01663662The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Heart Failure-Pilot Study
NCT04189705A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis
NCT00162942Study for the Treatment of Crohn's Disease With Adacolumn
NCT03828201Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB
NCT06628128A Study to Evaluate the Long-Term Safety and Efficacy of JNT-517 in Participants With Phenylketonuria
NCT00105196A Study of Aripiprazole in Patients With Major Depressive Disorder
NCT00545142Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness
NCT01711866A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease
NCT04258839Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148
NCT00234078Dose-response Study of OPC-12759 Ophthalmic Suspension
NCT00475319Late Phase 2 Study of OPC-12759 Ophthalmic Suspension
NCT03418675Brexpiprazole in Borderline Personality Disorder
NCT02293993Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia
NCT05593029A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder
NCT05463770A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophrenia
NCT06926829A Long-term Trial of EB-1020 in Adult Patients With ADHD
NCT00132886Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure
NCT03724942Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
NCT01944969Long-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder
NCT01994473Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia
NCT00940173Open-label Investigation of the Safety and Effectiveness of DIABECELL(R) in Patients With Type I Diabetes Mellitus
NCT01628965A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients
NCT00508157A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome
NCT03287869A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.
NCT03172871Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia
NCT02046564Assess the Efficacy and Safety of ASC-01 in Patients With Major Depressive Disorder
NCT01410188Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
NCT04233346The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation
NCT05190744Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration
NCT01727700Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder